This study is looking at whether using patient-specific 3D printed models during planning for surgery to remove bone tumors can improve outcomes. You might be eligible if you are at least 13 years old and have a bone tumor that needs surgery, such as sarcoma, Ewing sarcoma, chondrosarcoma, osteosarcoma, fibrous histiocytoma, or fibrosarcoma. Half of the participants will have their surgery planned using standard imaging (like CT/MRI scans) and a 3D printed model, while the other half will use only standard imaging. The main goal is to see if using 3D models can reduce the time spent in surgery. The study is currently unclear on its recruitment status and plans to enroll up to 150 people.

Study design

This is a multi-center, randomized controlled study involving up to 150 participants. Participants will be randomly assigned to one of two groups: one using 3D printed models for surgical planning and the other using only standard imaging.

What's involved

Participants will undergo surgical excision of their tumor. The study aims to measure operative time, blood loss, and postoperative adverse events.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, operative time, is measured from incision to closure. Secondary endpoints, such as reduction of blood loss and postoperative adverse events, are also assessed.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.